Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with Linezolid and Gentamicin

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 689-690

  Noskin, Gary A ^a,b   Siddiqui, Farida ^a,b   Stosor, Valentina ^a,b   Kruzynski, Julie ^a,b   Peterson, Lance R ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; PENICILLIN G; PIPERACILLIN; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CANCER CHEMOTHERAPY; CASE REPORT; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PRIORITY JOURNAL;

EID: 0033020360     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517221     Document Type: Article

References (10)

1. 1. Lai KK. Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med 1996;156:2579-84.
2. 2. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995;20:296-301.
3. 3. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522-7.
4. 4. Zurenko GE, Yagi BH, Schaadt RD, et al. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 1996;40:839-45.
5. 5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: approved standard. NCCLS document M7-A4. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
6. 6. Peterson LR, Shanholtzer CJ. Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev 1992;5:420-32.
7. 7. Murray BE. The life and times of enterococcus. Clin Microbiol Rev 1990; 3:46-65.
8. 8. Noskin GA. Vancomycin resistant enterococci: clinical, microbiological and epidemiological features. J Lab Clin Med 1997;130:14-20.
9. 9. Dever LL, Smith SM, Dejesus D, et al. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases. Microb Drug Resist 1996;2:407-13.
10. 10. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234-9.